FDA: Marketing Materials Encouraged Neurovascular Catheter Misuse
Executive Summary
Some manufacturers may be suggesting their guide catheters can be used to remove thrombus – an off-label use that could cause hemorrhage and other adverse events, FDA says.
You may also be interested in...
Stryker Devices Get First-Line US FDA Go-Ahead For Stroke
It’s a first-in-class indication for clot-retrieval devices that the firm gained in a 2011 acquisition.
Warning Letters And Close-Outs – September 2023
It was a quiet month for warning letters at the FDA last month, with the agency issuing no new warning letters and closing out only one.
Proposed Rule Would Apply FDA’s Diagnostic Rules To LDTs
A proposed rule from the US Food and Drug Administration would allow the agency to take on regulation of lab-developed tests by phasing out the previous approach of enforcement discretion